肝脏 ›› 2025, Vol. 30 ›› Issue (3): 366-370.

• 肝癌 • 上一篇    下一篇

肝动脉栓塞化疗联合三维适形放疗治疗中晚期HBV相关原发性肝癌患者的疗效观察

顾勣, 李榕华, 朱海燕, 董莉   

  1. 226600 江苏 海安市人民医院介入与血管外科(顾勣,李榕华),肿瘤科(朱海燕);无锡市第五人民医院影像科(董莉)
  • 收稿日期:2024-09-11 出版日期:2025-03-31 发布日期:2025-06-16
  • 通讯作者: 朱海燕,Email: justzhy789@126.com
  • 基金资助:
    江苏省卫生健康委医学科研立项项目(Z2023091)

Therapeutic effect of transcatheter arterial chemoembolization combined with three-dimensional conformal radiation therapy on patients with advanced hepatitis B primary liver cancer

GU Ji1, LI Rong-hua1, ZHU Hai-yan2, DONG Li3   

  1. 1. Department of Interventional and Vascular Surgery Oncology, Hai'an People's Hospital, Nantong, Jiangsu 226600, China;
    2. Department of Oncology, Hai'an People's Hospital, Nantong, Jiangsu 226600, China;
    3. Department of Image, Wuxi Fifth People's Hospital, Jiangsu 214001, China
  • Received:2024-09-11 Online:2025-03-31 Published:2025-06-16
  • Contact: ZHU Hai-yan, Email:justzhy789@126.com

摘要: 目的 分析肝动脉栓塞化疗(TACE)联合三维适形放疗(3D-CRT)治疗中晚期HBV相关原发性肝癌(PLC)患者的疗效。方法 搜集2019年1月—2024年6月海安市人民医院诊治的中晚期HBV相关PLC患者72例。按照既往指南,对纳入病例进行抗病毒治疗、TACE以及3D-CRT。利用实体瘤治疗反应评价标准进行治疗疗效评价,分为治疗有效组、治疗无效组,比较两组临床资料并分析影响TACE联合3D-CRT治疗中晚期PLC患者短期临床疗效的影响,同时分析治疗期间的不良反应。结果 TACE联合3D-CRT治疗后3个月进行疗效评价,其中治疗有效51例[完全缓解(CR)+部分缓解(PR)]、治疗无效21例[疾病稳定(SD)+疾病进展(PD)]。与治疗无效组比,治疗有效组AFP<400 μg/L、50~60 Gy放射治疗剂量、BCLC分期B期及Child-Pugh分级A级例数显著升高(P<0.05),同时肿瘤直径、大体肿瘤靶区明显降低(P<0.05)。多因素分析发现,AFP水平、大体肿瘤靶区、放射治疗剂量及Child-Pugh分级是TACE联合3D-CRT治疗中晚期PLC患者短期临床疗效的独立影响因素(P<0.05)。患者治疗期间不良反应包括TACE及3D-CRT期间的。在TACE期间,不良反应包括发热9例(12.5%)、上腹部痛7例(9.7%)、恶心呕吐5例(6.9%)。3D-CRT期间不良反应包括上腹饱胀感11例(15.3%)、粒细胞缺乏6例(8.3%)、胃部烧灼不适4例(5.5%)及放射性肝损伤3例(4.2%)。结论 TACE联合3D-CRT治疗中晚期HBV相关PLC具有良好的疗效,但疗效受到多种因素的影响,包括AFP水平、大体肿瘤靶区、放射治疗剂量及Child-Pugh分级。在临床实践中,应根据患者的个体差异调整治疗方案,以提高疗效并减少不良反应的发生。

关键词: 原发性肝癌, 肝动脉栓塞化疗, 三维适形放疗, 多因素分析, 放射性肝损伤

Abstract: Objective To analyze the efficacy of transcatheter arterial chemoembolization (TACE) combined with three-dimensional conformal radiation therapy (3D-CRT) in the treatment of patients with advanced hepatitis B primary liver cancer (PLC).Methods Between January 2019 and June 2024, 72 PLC patients with advanced hepatitis B were enrolled. According to the previous guidelines, the enrolled patients were treated with antiviral therapy, TACE and 3D-CRT. According to the evaluation standard of response to solid tumor treatment, the therapeutic effect was evaluated and divided into two groups: the effective group and the ineffective group. The clinical data of the two groups were compared and factors influencing the short-term clinical effect of TACE combined with 3D-CRT in the treatment of advanced PLC patients was analyzed, and the adverse reactions during the treatment were also analyzed.Results Three months after TACE combined with 3D-CRT treatment, the curative effect was evaluated, of which 51 cases were effective [complete remission (CR)+ partial remission (PR)] and 21 cases were ineffective [disease stability (SD)+disease progression (PD)]. Compared with the ineffective group, the cases of AFP<400μg/L, 50-60 Gy radiotherapy dose, BCLC stage B and Child-Pugh grade A in the effective group increased significantly (P<0.05), while the tumor diameter and gross tumor volume decreased significantly (P<0.05). Multivariate analysis showed that AFP level, gross tumor volume, radiation dose and Child-Pugh grade were independent factors influencing the short-term clinical efficacy of TACE combined with 3D-CRT in the treatment of advanced PLC patients (P<0.05). Adverse reactions during treatment included those during TACE and 3D-CRT. During TACE, the adverse reactions included fever in 9 cases (12.5%), epigastric pain in 7 cases (9.7%) and nausea and vomiting in 5 cases (6.9%). Adverse reactions during 3D-CRT included epigastric fullness in 11 cases (15.3%), agranulocytosis in 6 cases (8.3%), gastric burning discomfort in 4 cases (5.5%) and radiation-induced liver damage in 3 cases (4.2%).Conclusion TACE combined with 3D-CRT has a good curative effect on PLC in the treatment of advanced hepatitis B, but the curative effect is affected by many factors, including AFP level, gross gross tumor volume, radiation dose and Child-Pugh classification. In clinical practice, the treatment plan should be adjusted according to the individual differences of patients, so as to improve the curative effect and reduce the occurrence of adverse reactions.

Key words: Primary liver cancer, Transcatheter arterial chemoembolization, Three-dimensional conformal radiation therapy, Multivariate analysis, Radioactive liver damage